| Citation: | Zeng Z,Peng YZ,Yuan ZQ.Research advances of sepsis biomarkers[J].Chin J Burns Wounds,2023,39(7):679-684.DOI: 10.3760/cma.j.cn501225-20230320-00086.
|
| [1] |
ZhangP, ZouB, LiouYC, et al. The pathogenesis and diagnosis of sepsis post burn injury[J/OL]. Burns Trauma, 2021,9:tkaa047[2023-03-20]. https://pubmed.ncbi.nlm.nih.gov/33654698/. DOI: 10.1093/burnst/tkaa047.
|
| [2] |
RuddKE, JohnsonSC, AgesaKM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study[J]. Lancet, 2020,395(10219):200-211. DOI: 10.1016/S0140-6736(19)32989-7.
|
| [3] |
PierrakosC, VincentJL. Sepsis biomarkers: a review[J]. Crit Care, 2010,14(1):R15. DOI: 10.1186/cc8872.
|
| [4] |
SinhaM, JupeJ, MackH, et al. Emerging technologies for molecular diagnosis of sepsis[J]. Clin Microbiol Rev, 2018,31(2) :e00089-17. DOI: 10.1128/CMR.00089-17.
|
| [5] |
LippiG. Sepsis biomarkers: past, present and future[J]. Clin Chem Lab Med, 2019,57(9):1281-1283. DOI: 10.1515/cclm-2018-1347.
|
| [6] |
Van WyngeneL, VandewalleJ, LibertC. Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last?[J]. EMBO Mol Med, 2018,10(8):e8712. DOI: 10.15252/emmm.201708712.
|
| [7] |
Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework[J]. Clin Pharmacol Ther, 2001, 69(3):89-95. DOI: 10.1067/mcp.2001.113989.
|
| [8] |
PierrakosC, VelissarisD, BisdorffM, et al. Biomarkers of sepsis: time for a reappraisal[J]. Crit Care, 2020,24(1):287. DOI: 10.1186/s13054-020-02993-5.
|
| [9] |
LiS, RongH, GuoQ, et al. Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis[J]. J Res Med Sci, 2016,21:39. DOI: 10.4103/1735-1995.183996.
|
| [10] |
TanJ, LiN, GongY, et al. Procalcitonin kinetics early after severe burn injury and its value in diagnosis of sepsis[J]. Burns, 2021,47(8):1802-1809. DOI: 10.1016/j.burns.2021.02.024.
|
| [11] |
KahnF, TverringJ, MellhammarL, et al. Heparin-binding protein as a prognostic biomarker of sepsis and disease severity at the emergency department[J]. Shock, 2019,52(6):e135-e145. DOI: 10.1097/SHK.0000000000001332.
|
| [12] |
KleinHJ, NiggemannP, BuehlerPK, et al. Pancreatic stone protein predicts sepsis in severely burned patients irrespective of trauma severity: a monocentric observational study[J]. Ann Surg, 2021,274(6):e1179-e1186. DOI: 10.1097/SLA.0000000000003784.
|
| [13] |
YuMH, ChenMH, HanF, et al. Prognostic value of the biomarkers serum amyloid A and nitric oxide in patients with sepsis[J]. Int Immunopharmacol, 2018,62:287-292. DOI: 10.1016/j.intimp.2018.07.024.
|
| [14] |
DoganyigitZ, ErogluE, AkyuzE. Inflammatory mediators of cytokines and chemokines in sepsis: from bench to bedside[J]. Hum Exp Toxicol, 2022,41:9603271221078871. DOI: 10.1177/09603271221078871.
|
| [15] |
LiuG, JiangC, LinX, et al. Point-of-care detection of cytokines in cytokine storm management and beyond: significance and challenges[J]. View (Beijing), 2021,2(4):20210003. DOI: 10.1002/VIW.20210003.
|
| [16] |
KangS, KishimotoT. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms[J]. Exp Mol Med, 2021,53(7):1116-1123. DOI: 10.1038/s12276-021-00649-0.
|
| [17] |
LingH, ChenM, DaiJ, et al. Evaluation of qSOFA combined with inflammatory mediators for diagnosing sepsis and predicting mortality among emergency department[J]. Clin Chim Acta, 2023,544:117352. DOI: 10.1016/j.cca.2023.117352.
|
| [18] |
YuB, ChenM, ZhangY, et al. Diagnostic and prognostic value of interleukin-6 in emergency department sepsis patients[J]. Infect Drug Resist, 2022,15:5557-5566. DOI: 10.2147/IDR.S384351.
|
| [19] |
KarakikeE, AdamiME, LadaM, et al. Late peaks of HMGB1 and sepsis outcome: evidence for synergy with chronic inflammatory disorders[J]. Shock, 2019,52(3):334-339. DOI: 10.1097/SHK.0000000000001265.
|
| [20] |
Beltrán-GarcíaJ, ManclúsJJ, García-LópezEM, et al. Comparative analysis of chromatin-delivered biomarkers in the monitoring of sepsis and septic shock: a pilot study[J]. Int J Mol Sci, 2021,22(18):9935. DOI: 10.3390/ijms22189935.
|
| [21] |
TextorisJ, GordonAC. Sepsis: who will shoot first? Pharma or diagnostics?[J]. Intensive Care Med, 2018,44(8):1331-1333. DOI: 10.1007/s00134-018-5234-5.
|
| [22] |
BlotM, ZeggayA, Aho-GleleLS, et al. Is blood lymphocyte count a prognostic biomarker in Staphylococcus aureus bacteremia?[J]. J Investig Med, 2022, 70(7):1549-1552. DOI: 10.1136/jim-2022-002356.
|
| [23] |
ZhaoPY, YaoRQ, ZhengLY, et al. Nuclear fragile X mental retardation-interacting protein 1-mediated ribophagy protects T lymphocytes against apoptosis in sepsis[J/OL]. Burns Trauma, 2023,11:tkac055[2023-03-20]. https://pubmed.ncbi.nlm.nih.gov/36873287/. DOI: 10.1093/burnst/tkac055.
|
| [24] |
LiuB, DuH, ZhangJ, et al. Developing a new sepsis screening tool based on lymphocyte count, international normalized ratio and procalcitonin (LIP score)[J]. Sci Rep, 2022,12(1):20002. DOI: 10.1038/s41598-022-16744-9.
|
| [25] |
WuHP, ChuangLP, LiuPH, et al. Decreased monocyte HLA-DR expression in patients with sepsis and acute kidney injury[J]. Medicina (Kaunas), 2022,58(9):1198. DOI: 10.3390/medicina58091198.
|
| [26] |
XuJ, LiJ, XiaoK, et al. Dynamic changes in human HLA-DRA gene expression and Th cell subsets in sepsis: Indications of immunosuppression and associated outcomes[J]. Scand J Immunol, 2020,91(1):e12813. DOI: 10.1111/sji.12813.
|
| [27] |
LeijteGP, RimmeléT, KoxM, et al. Monocytic HLA-DR expression kinetics in septic shock patients with different pathogens, sites of infection and adverse outcomes[J]. Crit Care, 2020,24(1):110. DOI: 10.1186/s13054-020-2830-x.
|
| [28] |
LiuQ, LiCS. Programmed cell death-1/programmed death-ligand 1 pathway: a new target for sepsis[J]. Chin Med J (Engl), 2017,130(8):986-992. DOI: 10.4103/0366-6999.204113.
|
| [29] |
ZhangT, Yu-JingL, MaT. Role of regulation of PD-1 and PD-L1 expression in sepsis[J]. Front Immunol, 2023,14:1029438. DOI: 10.3389/fimmu.2023.1029438.
|
| [30] |
ZhaoY, JiaY, LiC, et al. Predictive value of soluble programmed death-1 for severe sepsis and septic shock during the first week in an intensive care unit[J]. Shock, 2019,51(3):289-297. DOI: 10.1097/SHK.0000000000001171.
|
| [31] |
WilsonJK, ZhaoY, SingerM, et al. Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study[J]. Crit Care, 2018,22(1):95. DOI: 10.1186/s13054-018-2020-2.
|
| [32] |
JiangW, LiX, DingH, et al. PD-1 in Tregs predicts the survival in sepsis patients using sepsis-3 criteria: a prospective, two-stage study[J]. Int Immunopharmacol, 2020,89(Pt A):107175. DOI: 10.1016/j.intimp.2020.107175.
|
| [33] |
LiuM, ZhangX, ChenH, et al. Serum sPD-L1, upregulated in sepsis, may reflect disease severity and clinical outcomes in septic patients[J]. Scand J Immunol, 2017,85(1):66-72. DOI: 10.1111/sji.12509.
|
| [34] |
BakhshianiZ, FouladiS, MohammadzadehS, et al. Correlation of sPD1 with procalcitonin and C-reactive protein levels in patients with sepsis[J]. Cell J, 2021,23(1):14-20. DOI: 10.22074/cellj.2021.6941.
|
| [35] |
Andaluz-OjedaD, NguyenHB, Meunier-BeillardN, et al. Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity[J]. Ann Intensive Care, 2017,7(1):15. DOI: 10.1186/s13613-017-0238-9.
|
| [36] |
HsiaoSY, KungCT, TsaiNW, et al. Concentration and value of endocan on outcome in adult patients after severe sepsis[J]. Clin Chim Acta, 2018,483:275-280. DOI: 10.1016/j.cca.2018.05.007.
|
| [37] |
HoshinoK, KitamuraT, NakamuraY, et al. Usefulness of plasminogen activator inhibitor-1 as a predictive marker of mortality in sepsis[J]. J Intensive Care, 2017,5:42. DOI: 10.1186/s40560-017-0238-8.
|
| [38] |
ZhouW, RaoH, DingQ, et al. Soluble CD14 subtype in peripheral blood is a biomarker for early diagnosis of sepsis[J]. Lab Med, 2020,51(6):614-619. DOI: 10.1093/labmed/lmaa015.
|
| [39] |
QinQ, LiangL, XiaY. Diagnostic and prognostic predictive values of circulating sTREM-1 in sepsis: a meta-analysis[J]. Infect Genet Evol, 2021,96:105074. DOI: 10.1016/j.meegid.2021.105074.
|
| [40] |
SunB, GuoS. miR-486-5p serves as a diagnostic biomarker for sepsis and its predictive value for clinical outcomes[J]. J Inflamm Res, 2021,14:3687-3695. DOI: 10.2147/JIR.S323433.
|
| [41] |
WangR, ZhaoJ, WeiQ, et al. Potential of circulating lncRNA CASC2 as a biomarker in reflecting the inflammatory cytokines, multi-organ dysfunction, disease severity, and mortality in sepsis patients[J]. J Clin Lab Anal, 2022,36(8):e24569. DOI: 10.1002/jcla.24569.
|
| [42] |
HausfaterP, Robert BoterN, Morales IndianoC, et al. Monocyte distribution width (MDW) performance as an early sepsis indicator in the emergency department: comparison with CRP and procalcitonin in a multicenter international European prospective study[J]. Crit Care, 2021,25(1):227. DOI: 10.1186/s13054-021-03622-5.
|
| [43] |
VellyL, VolantS, FittingC, et al. Optimal combination of early biomarkers for infection and sepsis diagnosis in the emergency department: the BIPS study[J]. J Infect, 2021,82(4):11-21. DOI: 10.1016/j.jinf.2021.02.019.
|
| [44] |
SongJ, MoonS, ParkDW, et al. Biomarker combination and SOFA score for the prediction of mortality in sepsis and septic shock: a prospective observational study according to the Sepsis-3 definitions[J]. Medicine (Baltimore), 2020,99(22):e20495. DOI: 10.1097/MD.0000000000020495.
|
| [45] |
LiuJ, BaiC, LiB, et al. Mortality prediction using a novel combination of biomarkers in the first day of sepsis in intensive care units[J]. Sci Rep, 2021,11(1):1275. DOI: 10.1038/s41598-020-79843-5.
|
| [46] |
LinM, ZhangL, TangX, et al. The value of neutrophil/lymphocyte ratio combined with red blood cell distribution width in evaluating the prognosis of emergency patients with sepsis[J]. Emerg Med Int, 2022, 2022:1673572. DOI: 10.1155/2022/1673572.
|
Copyright © Chinese Journal of Burns京ICP备07035254号-14
E-mail：shaoshangzazhi@163.com
Supported by:
Beijing Renhe Information Technology Co. Ltd
Yin X,Zhou WF,Hou WJ,et al.Effects of non-muscle myosin Ⅱ silenced bone marrow-derived mesenchymal stem cells transplantation on lung extracellular matrix in rats after endotoxin/lipopolysaccharide-induced acute lung injury[J].Chin J Burns Wounds,2022,38(5):422-433.DOI: 10.3760/cma.j.cn501225-20220212-00024.
DownLoad: